XML 65 R44.htm IDEA: XBRL DOCUMENT v3.24.0.1
Supplemental Financial Information (Tables)
12 Months Ended
Dec. 31, 2023
Condensed Financial Information Disclosure [Abstract]  
Supplemental financial position The following supplemental financial information illustrates the consolidating effects of the Consolidated Funds on the
Company’s financial position as of December 31, 2023 and 2022 and results of operations for the years ended December 31,
2023, 2022 and 2021. The supplemental statement of cash flows is presented without effects of the Consolidated Funds.
 
As of December 31, 2023
 
Consolidated
Operating
Entities
Consolidated
Funds
Eliminations
Consolidated
 
(Dollars in millions)
Assets
Cash and cash equivalents
$1,440.3
$
$
$1,440.3
Cash and cash equivalents held at Consolidated Funds
346.0
346.0
Restricted cash
1.8
1.8
Investments, including performance allocations of $6,169.9
10,104.5
(149.2)
9,955.3
Investments of Consolidated Funds
7,313.9
(60.8)
7,253.1
Due from affiliates and other receivables, net
1,009.2
(317.6)
691.6
Due from affiliates and other receivables of Consolidated Funds, net
141.0
141.0
Fixed assets, net
161.5
161.5
Lease right-of-use assets, net
332.2
332.2
Deposits and other
66.0
4.6
70.6
Intangible assets, net
766.1
766.1
Deferred tax assets
16.5
16.5
Total assets
$13,898.1
$7,805.5
$(527.6)
$21,176.0
Liabilities and equity
Debt obligations
$2,281.0
$
$
$2,281.0
Loans payable of Consolidated Funds
6,796.4
(309.9)
6,486.5
Accounts payable, accrued expenses and other liabilities
333.8
333.8
Accrued compensation and benefits
4,922.2
4,922.2
Due to affiliates
269.6
6.3
275.9
Deferred revenue
140.3
140.3
Deferred tax liabilities
45.3
45.3
Other liabilities of Consolidated Funds
374.4
374.4
Lease liabilities
488.1
488.1
Accrued giveback obligations
44.0
44.0
Total liabilities
8,524.3
7,177.1
(309.9)
15,391.5
Common stock
3.6
3.6
Additional paid-in capital
3,403.0
223.8
(223.8)
3,403.0
Retained earnings
2,082.1
2,082.1
Accumulated other comprehensive loss
(292.7)
(10.7)
6.1
(297.3)
Non-controlling interests in consolidated entities
177.8
415.3
593.1
Total equity
5,373.8
628.4
(217.7)
5,784.5
Total liabilities and equity
$13,898.1
$7,805.5
$(527.6)
$21,176.0
As of December 31, 2022
 
Consolidated
Operating
Entities
Consolidated
Funds
Eliminations
Consolidated
 
(Dollars in millions)
Assets
Cash and cash equivalents
$1,360.7
$
$
$1,360.7
Cash and cash equivalents held at Consolidated Funds
209.0
209.0
Restricted cash
0.8
0.8
Corporate treasury investments
20.0
20.0
Investments, including performance allocations of $7,117.7
10,989.9
(222.0)
10,767.9
Investments of Consolidated Funds
6,894.4
6,894.4
Due from affiliates and other receivables, net
960.5
(381.1)
579.4
Due from affiliates and other receivables of Consolidated Funds, net
101.9
101.9
Fixed assets, net
139.9
139.9
Lease right-of-use assets, net
337.0
337.0
Deposits and other
70.4
8.0
78.4
Intangible assets, net
897.8
897.8
Deferred tax assets
15.8
15.8
Total assets
$14,792.8
$7,213.3
$(603.1)
$21,403.0
Liabilities and equity
Debt obligations
$2,271.7
$
$
$2,271.7
Loans payable of Consolidated Funds
6,279.7
(374.5)
5,905.2
Accounts payable, accrued expenses and other liabilities
369.2
369.2
Accrued compensation and benefits
4,320.9
4,320.9
Due to affiliates
346.1
16.5
(0.1)
362.5
Deferred revenue
126.4
126.4
Deferred tax liabilities
402.7
402.7
Other liabilities of Consolidated Funds
279.7
(0.4)
279.3
Lease liabilities
502.9
502.9
Accrued giveback obligations
40.9
40.9
Total liabilities
8,380.8
6,575.9
(375.0)
14,581.7
Common stock
3.6
3.6
Additional paid-in capital
3,138.5
238.7
(238.7)
3,138.5
Retained earnings
3,401.1
3,401.1
Accumulated other comprehensive loss
(319.5)
(13.3)
10.6
(322.2)
Non-controlling interests in consolidated entities
188.3
412.0
600.3
Total equity
6,412.0
637.4
(228.1)
6,821.3
Total liabilities and equity
$14,792.8
$7,213.3
$(603.1)
$21,403.0
Supplemental results of operations
 
Year Ended December 31, 2023
 
Consolidated
Operating
Entities
Consolidated
Funds
Eliminations
Consolidated
 
(Dollars in millions)
Revenues
Fund management fees
$2,074.3
$
$(31.1)
$2,043.2
Incentive fees
96.2
(2.5)
93.7
Investment income (loss)
Performance allocations
(85.0)
(3.6)
(88.6)
Principal investment income
160.2
(26.8)
133.4
Total investment income
75.2
(30.4)
44.8
Interest and other income
222.7
(10.6)
212.1
Interest and other income of Consolidated Funds
570.1
570.1
Total revenues
2,468.4
570.1
(74.6)
2,963.9
Expenses
Compensation and benefits
Cash-based compensation and benefits
1,023.7
1,023.7
Equity-based compensation
249.1
249.1
Performance allocations and incentive fee related compensation
1,103.7
1,103.7
Total compensation and benefits
2,376.5
2,376.5
General, administrative and other expenses
651.4
0.7
652.1
Interest
123.8
123.8
Interest and other expenses of Consolidated Funds
460.3
(41.2)
419.1
Other non-operating expenses
0.2
0.2
Total expenses
3,151.9
460.3
(40.5)
3,571.7
Other income
Net investment income of Consolidated Funds
6.9
6.9
Income (loss) before provision for income taxes
(683.5)
116.7
(34.1)
(600.9)
Benefit for income taxes
(104.2)
(104.2)
Net income (loss)
(579.3)
116.7
(34.1)
(496.7)
Net income attributable to non-controlling interests in consolidated entities
29.1
82.6
111.7
Net income (loss) attributable to The Carlyle Group Inc.
$(608.4)
$116.7
$(116.7)
$(608.4)
 
Year Ended December 31, 2022
 
Consolidated
Operating
Entities
Consolidated
Funds
Eliminations
Consolidated
 
(Dollars in millions)
Revenues
Fund management fees
$2,056.7
$
$(26.6)
$2,030.1
Incentive fees
63.8
(0.1)
63.7
Investment income
Performance allocations
1,332.8
(5.3)
1,327.5
Principal investment income
542.5
28.0
570.5
Total investment income
1,875.3
22.7
1,898.0
Interest and other income
154.1
(18.2)
135.9
Interest and other income of Consolidated Funds
311.0
311.0
Total revenues
4,149.9
311.0
(22.2)
4,438.7
Expenses
Compensation and benefits
Cash-based compensation and benefits
1,052.0
1,052.0
Equity-based compensation
154.0
154.0
Performance allocations and incentive fee related compensation
719.9
719.9
Total compensation and benefits
1,925.9
1,925.9
General, administrative and other expenses
576.2
(0.4)
575.8
Interest
110.4
110.4
Interest and other expenses of Consolidated Funds
255.3
(43.7)
211.6
Other non-operating expenses
1.0
1.0
Total expenses
2,613.5
255.3
(44.1)
2,824.7
Other loss
Net investment loss of Consolidated Funds
(41.5)
(41.5)
Income before provision for income taxes
1,536.4
14.2
21.9
1,572.5
Provision for income taxes
287.8
287.8
Net income
1,248.6
14.2
21.9
1,284.7
Net income attributable to non-controlling interests in consolidated entities
23.6
36.1
59.7
Net income attributable to The Carlyle Group Inc.
$1,225.0
$14.2
$(14.2)
$1,225.0
 
 
Year Ended December 31, 2021
 
Consolidated
Operating
Entities
Consolidated
Funds
Eliminations
Consolidated
 
(Dollars in millions)
Revenues
Fund management fees
$1,691.5
$
$(24.0)
$1,667.5
Incentive fees
48.8
48.8
Investment income
Performance allocations
6,084.6
6,084.6
Principal investment income
666.0
(28.7)
637.3
Total investment income
6,750.6
(28.7)
6,721.9
Interest and other income
112.7
(22.0)
90.7
Interest and other income of Consolidated Funds
253.2
253.2
Total revenues
8,603.6
253.2
(74.7)
8,782.1
Expenses
Compensation and benefits
Cash-based compensation and benefits
908.0
908.0
Equity-based compensation
163.1
163.1
Performance allocations and incentive fee related compensation
2,961.0
2,961.0
Total compensation and benefits
4,032.1
4,032.1
General, administrative and other expenses
431.9
(0.2)
431.7
Interest
113.3
113.3
Interest and other expenses of Consolidated Funds
217.8
(39.3)
178.5
Other non-operating expenses
1.5
1.5
Total expenses
4,578.8
217.8
(39.5)
4,757.1
Other income
Net investment gains of Consolidated Funds
2.5
2.5
Income before provision for income taxes
4,024.8
37.9
(35.2)
4,027.5
Provision for income taxes
982.3
982.3
Net income
3,042.5
37.9
(35.2)
3,045.2
Net income attributable to non-controlling interests in consolidated entities
67.8
2.7
70.5
Net income attributable to The Carlyle Group Inc.
$2,974.7
$37.9
$(37.9)
$2,974.7
Supplemental statement of cash flows
 
Year Ended December 31,
 
2023
2022
2021
 
(Dollars in millions)
Cash flows from operating activities
Net income (loss)
$(579.3)
$1,248.6
$3,042.5
Adjustments to reconcile net income (loss) to net cash flows from operating activities:
Depreciation and amortization
180.6
147.4
52.0
Equity-based compensation
249.1
154.0
163.1
Right-of-use asset impairment, net of broker fees
24.8
Non-cash performance allocations and incentive fees, net
1,569.2
387.5
(1,670.7)
Non-cash principal investment income
(130.7)
(501.5)
(628.9)
Other non-cash amounts
23.8
(10.3)
29.1
Purchases of investments
(345.8)
(737.7)
(384.5)
Proceeds from the sale of investments
485.9
498.0
708.3
Payments of contingent consideration
(68.6)
(5.7)
(48.0)
Change in deferred taxes, net
(368.7)
(73.2)
508.4
Change in due from affiliates and other receivables
(33.5)
(82.3)
(25.1)
Change in deposits and other
6.3
(11.8)
(12.5)
Change in accounts payable, accrued expenses and other liabilities
(33.2)
(14.3)
105.7
Change in accrued compensation and benefits
10.6
(135.4)
239.0
Change in due to affiliates
(14.5)
1.7
0.2
Change in lease right-of-use asset and lease liability
(10.8)
(8.8)
4.5
Change in deferred revenue
15.3
4.5
35.1
Net cash provided by operating activities
955.7
860.7
2,143.0
Cash flows from investing activities
Purchases of corporate treasury investments
(187.3)
(69.6)
Proceeds from corporate treasury investments
210.3
50.0
Purchases of fixed assets, net
(66.6)
(40.6)
(41.4)
Purchase of Abingworth, net of cash acquired
(150.2)
Purchase of CBAM intangibles and investments
(618.4)
Proceeds from sale of MRE, net of cash sold
5.9
Proceeds from sale of Brazil management entity, net of cash sold
3.3
Net cash used in investing activities
(43.6)
(828.8)
(32.2)
Cash flows from financing activities
Borrowings under credit facilities
70.0
Repayments under credit facilities
(70.0)
Issuance of 4.625% subordinated notes due 2061, net of financing costs
484.1
Repurchase of 3.875% senior notes due 2023
(259.9)
Proceeds from CLO borrowings, net of financing costs
12.0
73.2
111.7
Payments on CLO borrowings
(17.2)
(16.7)
(232.5)
Payments of contingent consideration
(0.1)
Dividends to common stockholders
(497.7)
(443.6)
(355.8)
Payment of deferred consideration for Carlyle Holdings units
(68.8)
(68.8)
(68.8)
Contributions from non-controlling interest holders
11.8
9.2
19.4
Distributions to non-controlling interest holders
(64.0)
(78.7)
(74.5)
Common shares issued for performance allocations
38.9
4.8
Common shares repurchased
(203.5)
(185.6)
(161.8)
Change in due to/from affiliates financing activities
(16.2)
(456.2)
(68.7)
Net cash used in financing activities
(843.6)
(1,128.3)
(602.1)
Effect of foreign exchange rate changes
12.1
(17.2)
(23.2)
Increase (decrease) in cash, cash equivalents and restricted cash
80.6
(1,113.6)
1,485.5
Cash, cash equivalents and restricted cash, beginning of period
1,361.5
2,475.1
989.6
Cash, cash equivalents and restricted cash, end of period
$1,442.1
$1,361.5
$2,475.1
Supplemental non-cash disclosures
Issuance of common shares related to the acquisition of CBAM and Abingworth
$
$219.5
$
Reconciliation of cash, cash equivalents and restricted cash, end of period:
Cash and cash equivalents
$1,440.3
$1,360.7
$2,469.5
Restricted cash
1.8
0.8
5.6
Total cash, cash equivalents and restricted cash, end of period
$1,442.1
$1,361.5
$2,475.1
Cash and cash equivalents held at Consolidated Funds
$346.0
$209.0
$147.8